Abstracts Archive - Page 1127 of 2425 - ACR Meeting Abstracts

Abstract Number: 1836 • 2018 ACR/ARHP Annual Meeting
Fibromyalgia Diagnosis and Biased Assessment: Sex, Prevalence, Biology and Bias
Brian Walitt¹, Frederick Wolfe², serge Perrot³, Johannes Rasker⁴ and Winfried Häuser⁵, ¹National Institutes of Health, National Institute of Nursing Research, Bethesda, MD, ²FORWARD, The National Databank for Rheumatic Diseases, Wichita, KS, ³Pain Clinic, Cochin-Hôtel Dieu Hospital, Paris, France, ⁴5Faculty of Behavioral Management & Social sciences, Psychology, Health & Technology, University of Twente, Enschede, the Netherlands, Enschede, Netherlands, ⁵Department of Psychosomatic Medicine and Psychotherapy, Technische Universität München, Munich, Germany
Background/Purpose: Multiple clinical and epidemiological studies have provided estimates of fibromyalgia prevalence and sex ratio, but different criteria sets and methodology, as well as bias,…
Abstract Number: 1837 • 2018 ACR/ARHP Annual Meeting
Validity of the Cognitive Index of the Symptom Severity Scale (SSS-Cog) in Assessing Cognitive Impairment in Fibromyalgia Patients
Odelia Elkana¹, Amir Falcofsky¹, Ran Shorer², Tamar Bar-On Kalfon², Roie Tzadok³ and Jacob N Ablin³, ¹School of Behavioral Sciences, Tel Aviv-Jaffa Academic College, Jaffa, Israel, Tel Aviv, Israel, ²Institute of Rheumatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, ³Internal Medicine H, Tel-Aviv Sourasky Medical Center, Israel & Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
Background/Purpose: Fibromyalgia Syndrome (FMS) is a multi-symptom disorder, characterized by somatic and cognitive manifestations, such as impaired working memory, executive function and attention (1,2). The…
Abstract Number: 1838 • 2018 ACR/ARHP Annual Meeting
Fibromyalgia, Beyond the 2016 Establishment. an Analysis of Novel Symptom Clusters for Differentiating Fibromyalgia from Other Chronic Pain Disorders
Kim Jones¹, Robert M. Bennett¹, Amanda W. St. John² and Ronald Friend³, ¹Schools of Nursing and Medicine, Oregon Health & Science University, Portland, OR, ²Anesthesiology and Pain Medicine, Oregon Health & Science University, Portland, OR, ³School of Nursing, Oregon Health & Science University, Portland, OR
Background/Purpose: Clinicians must commonly differentiate fibromyalgia (FM) from other chronic pain diagnoses. Numerous symptoms, including those from the 2016 criteria, have been proposed to accomplish…
Abstract Number: 1839 • 2018 ACR/ARHP Annual Meeting
Association of Diet Quality with Overall Fibromyalgia Impact, and Psychosocial and Quality of Life Outcomes in Women with Fibromyalgia
Mei Chung¹, Andrew Beauchesne², Zhuxuan Fu¹, Lori Lyn Price³ and Chenchen Wang⁴, ¹Department of Public Health and Community Medicine, Tufts University, School of Medicine, Boston, MA, ²Tufts University, School of Medicine, Boston, MA, ³Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, ⁴Division of Rheumatology, Center for Complementary and Integrative Medicine, Tufts Medical Center, Boston, MA
Background/Purpose: Lifestyle modifications, including of diet and exercise, have been widely disseminated for the prevention and treatment of chronic pain. However, the relationships between dietary…
Abstract Number: 1840 • 2018 ACR/ARHP Annual Meeting
Disease Activity in Rheumatoid Arthritis Patients Is Influenced By Countries’ Socioeconomics: Results from the Meteor Registry
Sytske Anne Bergstra¹, José Tavares Costa², David Vega-Morales³, Karen Salomon-Escoto⁴, Nimmisha Govind⁵, Cornelia F. Allaart¹ and Robert B.M. Landewé⁶, ¹Department of Rheumatology, LUMC, Leiden, Netherlands, ²Rheumatology, Unidade Local de Saúde do Alto Minho, Ponte de Lima, Portugal, ³Rheumatology, University Hospital “Dr. José Eleuterio González”, UANL, Monterrey, Mexico, ⁴University of Massachusetts Medical School, Rheumatology Center, UMass Memorial Medical Center, Worcester, MA, ⁵University of the Witwatersrand, Johannesburg, South Africa, ⁶Amsterdam Rheumatology & Immunology Center | Zuyderland Medical Center, Heerlen, Netherlands
Background/Purpose: The treatment and prognosis of rheumatoid arthritis (RA) patients have improved tremendously, but patients across the world may not benefit similarly. One of the…
Abstract Number: 1841 • 2018 ACR/ARHP Annual Meeting
Current Rheumatology Fellows Experiences with Health Disparities and Disparity Education: A Qualitative Study
Irene Blanco¹ and Cristina Gonzalez², ¹Rheumatology, Albert Einstein College of Medicine, Bronx, NY, ²Medicine, Albert Einstein College of Medicine, Bronx, NY
Background/Purpose: Health disparities (HD) are pervasive across all specialties including rheumatology; such that the ACGME has mandated that all programs teach house officers about HD.…
Abstract Number: 1842 • 2018 ACR/ARHP Annual Meeting
Implementation of an African American Popular Opinion Leader Model to Address Disparities in Lupus Knowledge and Care
Courtnie Phillip¹, Cianna Leatherwood², Elmer Freeman³, Gail Granville⁴, Gayna Sealy⁵, Toni Wiley⁵, Chase Correia⁶, Karen Mancera-Cuevas⁷, Patricia Canessa⁸, Rosalind Ramsey-Goldman⁹ and Candace H. Feldman², ¹Brigham and Women's Hospital, Boston, MA, ²Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, ³Northeastern University, Boston, MA, ⁴Women of Courage, Inc., Boston, MA, ⁵Sportsmen's Tennis and Enrichment Center, Dorchester, MA, ⁶Northwestern University, Chicago, IL, ⁷Rheumatology, Northwestern University, Chicago, IL, ⁸Illinois Public Health Association, Springfield, IL, ⁹FSM, Northwestern University, Chicago, IL
Background/Purpose: Lupus is a chronic, autoimmune disease that disproportionately affects African American individuals. Community-based educational interventions that capitalize on rich social networks can be used…
Abstract Number: 1843 • 2018 ACR/ARHP Annual Meeting
Improving Access to Rheumatology Care for High-Risk Lupus Patients Can Help Decrease Hospitalizations
Allen P. Anandarajah¹, Sean McMahon², Amanda Ostronic³, Changyong Feng⁴, Jennifer Anolik⁵ and Christopher T. Ritchlin⁶, ¹Dept of Rheumatology, Univ of Rochester Medical Ctr, Rochester, NY, ²Quality office, University of Rochester Medical Center, Rochester, NY, ³University of Rochester Medical Center, Rochester, NY, ⁴Statistics, University of Rochester, Rochester, NY, ⁵Medicine- Allergy, Immunology and Rheumatology, University of Rochester Medical Center, Rochester, NY, ⁶Division of Allergy/Immunology and Rheumatology and Center for Musculoskeletal Research, School of Medicine and Dentistry, University of Rochester Medical School, Rochester, New York, USA, Rochester, NY
Background/Purpose: We previously demonstrated that a small group of high risk, high cost patients (HRHC) account for majority of the hospitalizations, length of stay (LOS)…
Abstract Number: 1844 • 2018 ACR/ARHP Annual Meeting
Racial Disparities and Accelerated SLE Mortality from a Population-Based Registry: The Georgia Lupus Registry
S. Sam Lim¹, Charles G. Helmick², Gaobin Bao³, Caroline Gordon⁴, Jennifer M. Hootman² and Cristina Drenkard⁵, ¹Emory University School of Medicine, Atlanta, GA, ²Arthritis Program, Centers for Disease Control and Prevention, Atlanta, GA, ³Department of Medicine, Division of Rheumatology, Emory University School of Medicine, Atlanta, GA, ⁴Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom, ⁵Medicine/Rheumatology, Emory University, Atlanta, GA
Background/Purpose: Population-based SLE mortality studies have depended on administrative data from vital statistics records to identify cases. However, a high proportion of SLE deaths have…
Abstract Number: 1845 • 2018 ACR/ARHP Annual Meeting
Defining and Examining Retention in Care in an Urban Lupus Cohort
Umber Ahmad¹, Ian Chang², Marit Johnson³, Ann Rosenthal³, Amanda Perez⁴ and Christie M. Bartels⁴, ¹Consultant Care (CC111W) - Rheumatology/Medicine, Milwaukee VA Medical Center, Milwaukee, WI, ²Medicine/Rheumatology, Medical College of Wisconsin, Milwaukee, WI, ³Division of Rheumatology, Medical College of Wisconsin, Milwaukee, WI, ⁴Rheumatology/Medicine, University of Wisconsin - Madison, Madison, WI
Background/Purpose: Systemic Lupus Erythematous (SLE) disproportionately impacts black patients and those of low socioeconomic status who experience higher rates of kidney disease and premature mortality.…
Abstract Number: 1846 • 2018 ACR/ARHP Annual Meeting
Menarchal Status at Diagnosis and Final Height in Females with Childhood-Onset Systemic Lupus Erythematosus
Watchareewan Sontichai¹, Daniela Dominguez¹, Lawrence Ng¹, Deborah M. Levy¹, Jonathan Wasserman², Earl Silverman¹ and Linda Hiraki¹, ¹Division of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, ²Division of Endocrinology, The Hospital for Sick Children, Toronto, ON, Canada
Background/Purpose: The diagnosis of systemic lupus erythematosus (SLE) in childhood affects growth due to disease and therapy. To date, there are few studies of final…
Abstract Number: 1847 • 2018 ACR/ARHP Annual Meeting
Screening Youth with Lupus for Depression and Anxiety in Pediatric Rheumatology Clinics
Tamar Rubinstein¹, Marija Dionizovik-Dimanovski², Chelsey Smith³, Raphael Kraus⁴, Jordan T. Jones⁵, Julia Harris⁶, Martha Rodriguez⁷, Lauren Faust⁸, Beth Rutstein⁸, Rebecca Puplava⁹, Melissa Tesher⁹, Alaina M. Davis¹⁰, Karen Onel¹¹, Sangeeta Sule¹², Emily von Scheven¹³ and Andrea M. Knight¹⁴, ¹Pediatric Rheumatology, Albert Einstein College of Medicine, Children's Hospital at Montefiore, Bronx, NY, ²Pediatric Rheumatology, Children's Hospital at Montefiore, Bronx, NY, ³Children's Mercy Kansas City, Kansas City, MO, ⁴Children's Hospital at Montefiore, Bronx, NY, ⁵University of Kansas, Kansas City, KS, ⁶Children's Mercy - Kansas City, Kansas City, MO, ⁷Riley Children’s Hospital at Indiana, Indianapolis, IN, ⁸Children's Hospital of Philadelphia, Philadelphia, PA, ⁹University of Chicago Medicine, Chicago, IL, ¹⁰Division of Pediatric Rheumatology, Monroe Carell Junior Children's Hospital at Vanderbilt, Nashville, TN, ¹¹Hospital for Special Surgery, New York, NY, ¹²Pediatrics, Johns Hopkins University, Baltimore, MD, ¹³Pediatric Rheumatology, University of California San Francisco, San Francisco, CA, ¹⁴Center for Pediatric Clinical Effectiveness & PolicyLab, Children's Hospital of Philadelphia, Philadelphia, PA
Background/Purpose: Despite high rates of depression and anxiety in pediatric lupus, standardized mental health screening is not routinely practiced by pediatric rheumatologists. Our objectives were…
Abstract Number: 1848 • 2018 ACR/ARHP Annual Meeting
Cardiovascular Risk Factors in Adults with Juvenile Idiopathic Arthritis in Sustained Remission
Ivan Arias de la Rosa¹, Inmaculada Concepcion Aranda-Valera², Rosa Roldan², Maria Carmen Abalos-Aguilera¹, Maria Dolores de la Rosa-Garrido², Yolanda Jiménez-Gómez³, Carlos Perez-Sanchez³, Alejandro Escudero-Contreras¹, Chary Lopez-Pedrera², Eduardo Collantes-Estévez³ and Nuria Barbarroja³, ¹Rheumatology Service, IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain, ²IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain, ³Rheumatology service, IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain
Background/Purpose: Juvenile Idiopathic Arthritis (JIA) is one of the more common chronic diseases of childhood that often persists into adulthood and can result in significant…
Abstract Number: 1849 • 2018 ACR/ARHP Annual Meeting
Remission Status after 18 Years of Follow-up in the Population-Based Nordic Juvenile Idiopathic Arthritis (JIA) Cohort
Mia Glerup¹, Veronika Rypdal^2,3, Ellen Dalen Arnstad^4,5, Maria Ekelund^6,7, Suvi Peltoniemi⁸, Kristiina Aalto⁸, Marite Rygg^9,10, Peter Toftedal¹¹, Susan Nielsen¹¹, Anders Fasth¹², Lillemor Berntson¹³, Ellen Nordal^14,15 and Troels Herlin¹⁶, ¹Department of Pediatrics, Dept. of Pediatrics, Aarhus University Hospital, Denmark, Aarhus, Denmark, ²Dept. of Clin. Med, UIT The Arctic University of Norway, Tromsø, Norway, ³Dept. of Pediatrics, University Hospital of North Norway, Tromsø, Norway, ⁴Dept. Clin. and Mol. Med., NTNU, Norway, Trondheim, Norway, ⁵Dept. of Pediatrics, Levanger Hospital, Nord-Trøndelag, Norway, Trondheim, Norway, ⁶Department of Pediatrics, Dept. of Pediatrics, Ryhov County Hospital, Jonkoping, Sweden, Jonkoping, Sweden, ⁷Uppsala University, Uppsala, Sweden, Jonkobing, Sweden, ⁸Hospital for Children and Adolescents, University of Helsinki, Finland, Helsinki, Finland, ⁹Dep. Clin. and Mol. Med., Dept. Clin. and Mol. Med., NTNU, Norway, Trondheim, Norway, ¹⁰Department of Pediatrics, Dept. of Pediatrics, St. Olavs Hospital, Norway, Trondheim, Norway, ¹¹Department of Pediatrics, Dept. of Pediatrics, Copenhagen University Hospital, Denmark, Copenhagen, Denmark, ¹²Sahlgrenska Academy, University of Gothenburg, Sweden, Gothenburg, Sweden, ¹³Uppsala University, Uppsala, Sweden, Uppsala, Sweden, ¹⁴Departments of Pediatrics, Dept. of Pediatrics, University Hospital of North Norway, Tromsø, Norway, ¹⁵Department of Clinical Medicine, Dept. of Clin. Med, UIT The Arctic University of Norway, Tromsø, Norway, ¹⁶Dept. of Pediatrics, Aarhus University Hospital, Aarhus N, Denmark
Background/Purpose: Innovative changes towards targeted treatment have improved the outcome dramatically for juvenile idiopathic arthritis (JIA) but the question remains how well these patients perform…
Abstract Number: 1850 • 2018 ACR/ARHP Annual Meeting
A Population Based Study of High School Academic Outcomes in Individuals with Childhood-Onset Chronic Rheumatic Diseases in Manitoba, Canada
Siok Hoon Lily Lim^1,2, Ruth Ann Marrie³, Okechukwu Ekuma⁴, Marni Brownell⁴, Christine A. Peschken⁵, Carol A Hitchon⁶, Kerstin Gerhold^7,8 and Lisa Lix⁹, ¹Children's Hospital Research Institute of Manitoba, University of Manitoba, Winnipeg, MB, Canada, ²Pediatrics, University of MAnitoba, Winnipeg, MB, Canada, ³Internal Medicine, University of Manitoba, Winnipeg, MB, Canada, ⁴Manitoba Centre for Health Policy, University of Manitoba, Winnipeg, MB, Canada, ⁵RR 149G, University of Manitoba, Winnipeg, MB, Canada, ⁶University of Manitoba, Winnipeg, MB, Canada, ⁷Pediatrics, University of Manitoba, Winnipeg, MB, Canada, ⁸Faculty of Health Sciences, Children's Hospital Research Institute of Manitoba, Winnipeg, MB, Canada, ⁹Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada
Background/Purpose: Childhood-onset chronic rheumatic diseases (ChildCRD) are rheumatic diseases with onset <18 years old, including juvenile arthritis (JA) and systemic autoimmune rheumatic diseases (SARD). ChildCRD…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].